Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › GenDx Receives Canadian License for HLA Typing Software

GenDx Receives Canadian License for HLA Typing Software

Aug 24, 2017
|
staff reporter

NEW YORK (GenomeWeb) – Dutch genetic testing firm GenDx announced on Wednesday that it has received a medical device license from Canadian regulators for its NGSengine human leukocyte antigen (HLA) typing software.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
27
Featured Webinar

The Promise of Liquid Biopsy for Cancer Diagnostics and Therapeutic Monitoring: Are We There Yet?

Sponsored by
LGC SeraCare Life Sciences

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.

What's Popular?

In Sequencing

  1. Johns Hopkins-Led Team Launches Startup to Tackle Breast Cancer, Glioblastoma Applications

    Premium

  2. Swift Biosciences, BillionToOne Partner to Commercialize COVID-19 Test

  3. Clear Labs Nanopore Sequencing Coronavirus Test Gets FDA Emergency Use Authorization

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.